Zepbound 12.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FGSYT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,566
Award facts
- Contract value 100% obligated
- $12,566.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,566.30 on June 5, 2025, for the supply of Zepbound 12.5 mg/0.5 ml pens under a firm fixed-price contract with an ultimate completion date of June 6, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The award was made competitively with no set-aside designation, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
This procurement supports the Defense Logistics Agency's Medical Supply Chain operations, which provide pharmaceutical and medical supplies to military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities. Zepbound is a FDA-approved GLP-1 receptor agonist used in diabetes management, consistent with AmerisourceBergen's extensive portfolio of pharmaceutical deliveries under the DLA framework. The company's broad-based IDC with DLA enables flexible fulfillment of federal medical supply requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical devices, supporting global military healthcare programs.
Quick answers
Who was awarded contract SPE2DB25FGSYT?
SPE2DB25FGSYT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 5, 2025.
How much is contract SPE2DB25FGSYT worth?
The government has obligated $12,566 on SPE2DB25FGSYT.
Is contract SPE2DB25FGSYT an order under another contract?
Yes. SPE2DB25FGSYT is a delivery order under SPE2DB24D2215, an indefinite delivery contract.
Was contract SPE2DB25FGSYT competed?
The extent of competition for SPE2DB25FGSYT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award